Author:
Ishizuka Osamu,Nishizawa Osamu,Nishizawa Shuji,Satoh Tomoya,Wajiki Masahisa,Kiyokawa Hideo,Inoue Yoshihiro,Kobayashi Shinya,Mizusawa Hiroya,Nakagawa Tatsuo
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference11 articles.
1. Huggins C, Hodges CV (1941) Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1:293–297
2. Debruyne FM, Dijkman GA, Lee DC et al (1996) A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancer. J Urol 155:1352–1354
3. Fernandez del Moral P, Dijkman GA, Debruyne FM et al (1996) Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Dutch South East Cooperative Urological Group. Urology 48:894–900
4. Kotake T, Akaza H, Usami M et al (2001) Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer. Hinyokika Kiyo 47:349–361 (in Japanese)
5. Sobin LH, Wittekind Ch (eds) (2002) International Union Against Cancer (UICC): ‘‘TNM classification of malignant tumors’’, 6th edn. Wiley, New York
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献